** Shares of Atomo Diagnostics AT1.AX rise 6.3% to A$0.017
** Stock set for its strongest session since January 31, if current trend holds
** Medical device co says Thorne Harbour Health has placed an order worth ~230,000 for co's HIV self-tests to support initial national scale up of its CONNECT program
** Says HIV self-tests to be imported into New Zealand with launch of product through Chemist Warehouse
** 659,024 shares traded in stock's busiest session since March 11
** Stock down 10.5% YTD, including current session's moves
(Reporting by Manasi Dasa in Bengaluru)
((Manasi.DasaSundeep@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.